Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
$694K Buy
8,905
+529
+6% +$39.4K ﹤0.01% 1707
2023
Q4
$598K Sell
8,376
-383
-4% -$26.7K ﹤0.01% 1726
2023
Q3
$608K Sell
8,759
-458
-5% -$34.6K ﹤0.01% 1636
2023
Q2
$746K Buy
9,217
+1,138
+14% +$93K 0.01% 1443
2023
Q1
$652K Buy
8,079
+532
+7% +$42.8K ﹤0.01% 1520
2022
Q4
$565K Buy
7,547
+346
+5% +$24.6K ﹤0.01% 1556
2022
Q3
$465K Sell
7,201
-2,421
-25% -$168K 0.01% 1328
2022
Q2
$667K Buy
9,622
+1,535
+19% +$114K 0.01% 1094
2022
Q1
$621K Buy
8,087
+5,080
+169% +$365K 0.01% 1164
2021
Q4
$230K Buy
3,007
+164
+6% +$12.1K ﹤0.01% 1783
2021
Q3
$210K Buy
+2,843
New +$213K ﹤0.01% 1766
2020
Q3
Sell
-1,382
Closed -$79K 2002
2020
Q2
$79K Buy
+1,382
New +$67.8K ﹤0.01% 1655

Other funds holding HOLX

Cetera Advisor Networks's HOLX Position: Q1 2024 in Review

Cetera Advisor Networks increased its Hologic (HOLX) stake by 6.3% in Q1 2024, buying an estimated $39.4K and bringing the position to 8,905 shares worth $694K. The position accounts for ﹤0.01% of the portfolio, ranked #1707.

Cetera Advisor Networks first reported a position in HOLX in Q2 2020 and has held it in 12 quarters since. The position peaked at $746K in Q2 2023. 706 funds tracked by Wall St. Rank hold HOLX as of Q1 2024.

  • Cetera Advisor Networks held 8,905 shares of Hologic worth $694K as of Q1 2024.
  • Cetera Advisor Networks bought 529 Hologic shares in Q1 2024, an estimated $39.4K.
  • Hologic made up ﹤0.01% of Cetera Advisor Networks's portfolio in Q1 2024, its #1707 holding.
  • Cetera Advisor Networks first reported a position in Hologic in Q2 2020 and has held it in 12 quarters since.
  • Cetera Advisor Networks's Hologic position peaked at $746K in Q2 2023.
  • 706 funds tracked by Wall St. Rank held Hologic as of Q1 2024.

Based on Cetera Advisor Networks's 13F filing for Q1 2024, filed 15 May 2024.